 | • レポートコード：MRC2012A1679 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がんによる性食欲不振-悪液質症候群医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。がんによる性食欲不振-悪液質症候群医薬品の種類別市場規模（NEO-1940、C-1889、DLN-101、Foxo1-nRNA、AVGN-7、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Acacia Pharma Ltd、PsiOxus Therapeutics Ltd、Incyte Corp、Aeterna Zentaris Inc、Obexia AG、Aphios Corp、Viking Therapeutics Inc、Novartis AG、Lakewood-Amedex Inc、RaQualia Pharma Inc、 ・地域別グローバル市場分析 2015年-2020年 ・がんによる性食欲不振-悪液質症候群医薬品の北米市場（アメリカ、カナダ、メキシコ） ・がんによる性食欲不振-悪液質症候群医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がんによる性食欲不振-悪液質症候群医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がんによる性食欲不振-悪液質症候群医薬品の南米市場（ブラジル、アルゼンチン） ・がんによる性食欲不振-悪液質症候群医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：NEO-1940、C-1889、DLN-101、Foxo1-nRNA、AVGN-7、その他 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cancer Anorexia-Cachexia Syndrome Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Anorexia-Cachexia Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Anorexia-Cachexia Syndrome Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Anorexia-Cachexia Syndrome Drug market has been segmented into
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
By Application, Cancer Anorexia-Cachexia Syndrome Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Anorexia-Cachexia Syndrome Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Anorexia-Cachexia Syndrome Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Anorexia-Cachexia Syndrome Drug market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Anorexia-Cachexia Syndrome Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Anorexia-Cachexia Syndrome Drug Market Share Analysis
Cancer Anorexia-Cachexia Syndrome Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Anorexia-Cachexia Syndrome Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Anorexia-Cachexia Syndrome Drug sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Anorexia-Cachexia Syndrome Drug are:
Acacia Pharma Ltd
PsiOxus Therapeutics Ltd
Incyte Corp
Aeterna Zentaris Inc
Obexia AG
Aphios Corp
Viking Therapeutics Inc
Novartis AG
Lakewood-Amedex Inc
RaQualia Pharma Inc
Among other players domestic and global, Cancer Anorexia-Cachexia Syndrome Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Anorexia-Cachexia Syndrome Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, with price, sales, revenue and global market share of Cancer Anorexia-Cachexia Syndrome Drug in 2018 and 2019.
Chapter 3, the Cancer Anorexia-Cachexia Syndrome Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Anorexia-Cachexia Syndrome Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cancer Anorexia-Cachexia Syndrome Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cancer Anorexia-Cachexia Syndrome Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cancer Anorexia-Cachexia Syndrome Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 NEO-1940
1.2.3 C-1889
1.2.4 DLN-101
1.2.5 Foxo1-nRNA
1.2.6 AVGN-7
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Cancer Anorexia-Cachexia Syndrome Drug Market
1.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Acacia Pharma Ltd
2.1.1 Acacia Pharma Ltd Details
2.1.2 Acacia Pharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Acacia Pharma Ltd SWOT Analysis
2.1.4 Acacia Pharma Ltd Product and Services
2.1.5 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 PsiOxus Therapeutics Ltd
2.2.1 PsiOxus Therapeutics Ltd Details
2.2.2 PsiOxus Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PsiOxus Therapeutics Ltd SWOT Analysis
2.2.4 PsiOxus Therapeutics Ltd Product and Services
2.2.5 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Incyte Corp
2.3.1 Incyte Corp Details
2.3.2 Incyte Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Incyte Corp SWOT Analysis
2.3.4 Incyte Corp Product and Services
2.3.5 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aeterna Zentaris Inc
2.4.1 Aeterna Zentaris Inc Details
2.4.2 Aeterna Zentaris Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aeterna Zentaris Inc SWOT Analysis
2.4.4 Aeterna Zentaris Inc Product and Services
2.4.5 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Obexia AG
2.5.1 Obexia AG Details
2.5.2 Obexia AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Obexia AG SWOT Analysis
2.5.4 Obexia AG Product and Services
2.5.5 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aphios Corp
2.6.1 Aphios Corp Details
2.6.2 Aphios Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aphios Corp SWOT Analysis
2.6.4 Aphios Corp Product and Services
2.6.5 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Viking Therapeutics Inc
2.7.1 Viking Therapeutics Inc Details
2.7.2 Viking Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Viking Therapeutics Inc SWOT Analysis
2.7.4 Viking Therapeutics Inc Product and Services
2.7.5 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis AG SWOT Analysis
2.8.4 Novartis AG Product and Services
2.8.5 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Lakewood-Amedex Inc
2.9.1 Lakewood-Amedex Inc Details
2.9.2 Lakewood-Amedex Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Lakewood-Amedex Inc SWOT Analysis
2.9.4 Lakewood-Amedex Inc Product and Services
2.9.5 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 RaQualia Pharma Inc
2.10.1 RaQualia Pharma Inc Details
2.10.2 RaQualia Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 RaQualia Pharma Inc SWOT Analysis
2.10.4 RaQualia Pharma Inc Product and Services
2.10.5 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Anorexia-Cachexia Syndrome Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Cancer Anorexia-Cachexia Syndrome Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
4.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
4.5 South America Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Market Share by Country
5.1.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
5.3 Canada Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
6.3 UK Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
6.4 France Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
6.5 Russia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
6.6 Italy Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
7.3 Japan Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
7.4 Korea Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
7.5 India Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
7.7 Australia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Market Share by Country
8.1.1 South America Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Type (2015-2020)
10.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2015-2020)
11 Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment by Application
11.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
11.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2015-2020)
11.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Cancer Anorexia-Cachexia Syndrome Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025)
12.2.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025)
12.2.4 South America Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025)
12.3 Cancer Anorexia-Cachexia Syndrome Drug Market Forecast by Type (2021-2025)
12.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Type (2021-2025)
12.4 Cancer Anorexia-Cachexia Syndrome Drug Market Forecast by Application (2021-2025)
12.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Anorexia-Cachexia Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Acacia Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 9. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 10. Acacia Pharma Ltd SWOT Analysis
Table 11. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 12. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. PsiOxus Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 14. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 15. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 16. PsiOxus Therapeutics Ltd SWOT Analysis
Table 17. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 18. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Incyte Corp Basic Information, Manufacturing Base and Competitors
Table 20. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 21. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 22. Incyte Corp SWOT Analysis
Table 23. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 24. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Aeterna Zentaris Inc Basic Information, Manufacturing Base and Competitors
Table 26. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 27. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 28. Aeterna Zentaris Inc SWOT Analysis
Table 29. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 30. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Obexia AG Basic Information, Manufacturing Base and Competitors
Table 32. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 33. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 34. Obexia AG SWOT Analysis
Table 35. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 36. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Aphios Corp Basic Information, Manufacturing Base and Competitors
Table 38. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 39. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 40. Aphios Corp SWOT Analysis
Table 41. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 42. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Viking Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 45. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 46. Viking Therapeutics Inc SWOT Analysis
Table 47. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 48. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 50. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 51. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 52. Novartis AG SWOT Analysis
Table 53. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 54. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Lakewood-Amedex Inc Basic Information, Manufacturing Base and Competitors
Table 56. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 57. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 58. Lakewood-Amedex Inc SWOT Analysis
Table 59. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 60. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. RaQualia Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 62. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Major Business
Table 63. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Total Revenue (USD Million) (2017-2018)
Table 64. RaQualia Pharma Inc SWOT Analysis
Table 65. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product and Services
Table 66. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 71. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries (2015-2020)
Table 74. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries (2015-2020)
Table 76. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries (2015-2020)
Table 78. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries (2015-2020)
Table 84. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries (2015-2020)
Table 90. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 91. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2015-2020)
Table 92. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2015-2020) (USD Million)
Table 93. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2015-2020)
Table 94. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 95. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2015-2020)
Table 96. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Regions (2021-2025)
Table 98. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Type (2021-2025)
Table 100. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2021-2025)
Table 101. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Picture
Figure 2. Global Sales Market Share of Cancer Anorexia-Cachexia Syndrome Drug by Type in 2019
Figure 3. NEO-1940 Picture
Figure 4. C-1889 Picture
Figure 5. DLN-101 Picture
Figure 6. Foxo1-nRNA Picture
Figure 7. AVGN-7 Picture
Figure 8. Others Picture
Figure 9. Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Cancer Anorexia-Cachexia Syndrome Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturer in 2019
Figure 34. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Cancer Anorexia-Cachexia Syndrome Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Cancer Anorexia-Cachexia Syndrome Drug Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Regions (2015-2020)
Figure 41. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Regions in 2018
Figure 42. North America Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
Figure 43. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
Figure 45. South America Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020)
Figure 47. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries (2015-2020)
Figure 49. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries in 2018
Figure 50. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries in 2018
Figure 52. United States Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries in 2019
Figure 58. Germany Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Regions 2019
Figure 66. China Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries in 2019
Figure 73. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries in 2019
Figure 74. Brazil Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Cancer Anorexia-Cachexia Syndrome Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
癌性食欲不振-悪液質症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cancer Anorexia-Cachexia Syndrome Drug Market The global Cancer Anorexia-Cachexia Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Anorexia-Cachexia Syndrome Dru…- がん悪液質の世界市場（～2026年） Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. Market Analysis and Insights: Global Cancer Cachexia Market The global Cancer Cachexia mark…
- がん悪液質の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Cachexia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1917.4 million by 2025, from USD 1637 million in 2019. The Cancer Cachexia market…
- 神経性食欲不振症治療の世界市場（～2026年） Anorexia nervosa is a dietary disorder or eating disorder portrayed by an irregular low body weight, risky fear of putting on weight and a misshaped view of body weight. Individuals with anorexia put a high incentive on controlling their weight and shape, utilizing outrageous endeavors that have a t…
- レノックス・ガストー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lennox-Gastaut Syndrome Drug Market The global Lennox-Gastaut Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lennox-Gastaut Syndrome Drug Scope and Market Size Lennox…